Criado M, Flores O, Ortíz M C, Hidalgo F, Rodríguez-López A M, Eleno N, Atucha N M, Sánchez-Rodríguez A, Arévalo M, Garcia-Estañ J, López-Novoa J M
Instituto Reina Sofía de Investigaciones Nefrológicas, Departamento de Fisiología y Farmacología, Facultad de Medicina, Universidad de Salamanca, Spain.
Hepatology. 1997 Aug;26(2):268-76. doi: 10.1002/hep.510260203.
Recent work indicates that nitric oxide (NO) plays an important role in the systemic and renal alterations of cirrhosis. In the present study, we have evaluated whether the inducible NO synthase (iNOS) isoform participates in the enhanced renal and systemic NO production of a rat model of cirrhosis. In vitro and in vivo experiments were performed in rats subjected to chronic bile duct ligation (BDL) and in sham-operated (SO) animals. Plasma nitrite (3.1 +/- 0.1 micromol/L in SO and 6.6 +/- 0.2 micromol/L in BDL), glomerular nitrite production (6.4 +/- 0.1 vs. 9.8 +/- 0.1 nmol/24h/7,000 glomeruli, respectively), and mononuclear lymphocyte cells nitrite production (0.3 +/- 0.04 vs. 0.6 +/- 0.12 nmol/10(6) cells, respectively) were all significantly higher in BDL than in SO. Moreover, mononuclear lymphocytes and glomeruli from BDL rats showed an increased expression of macrophage-type iNOS, detected by Western blot. Kidneys from BDL animals also showed an increased calcium-independent NO synthase activity, compared with those from SO rats. Constitutive endothelial-type NO synthase expression in glomeruli or the activity of calcium-dependent NO synthase in whole kidney did not show differences between BDL and SO rats. In cultured mesangial cells from normal rats, the addition of plasma from BDL but not of plasma from SO significantly stimulated (35%) nitrite production and increased the expression of macrophage-type iNOS. In addition, administration of aminoguanidine (AG), a preferential iNOS inhibitor, elevated dose-dependently mean arterial pressure in both groups, but this increase was greater in BDL (26.5 +/- 4.4 mm hg) than in SO (13.6 +/- 2.6). In BDL, AG also increased sodium and water excretion and glomerular filtration rate. In contrast, there were only small nonsignificant changes in SO animals. Therefore, these results indicate that the expression, activity and production of NO in kidneys, glomeruli, and mononuclear lymphocyte cells is elevated in BDL rats, and this is partly because of a plasma-derived substance(s), which stimulates iNOS formation. The amelioration of the arterial hypotension and the associated reduced excretory levels of these cirrhotic animals by aminoguanidine further support the involvement of the inducible NO synthase isoform in the renal alterations observed in BDL animals.
近期研究表明,一氧化氮(NO)在肝硬化的全身及肾脏改变中起重要作用。在本研究中,我们评估了诱导型一氧化氮合酶(iNOS)同工型是否参与了肝硬化大鼠模型中肾脏及全身NO生成的增加。对接受慢性胆管结扎(BDL)的大鼠及假手术(SO)动物进行了体外和体内实验。血浆亚硝酸盐水平(SO组为3.1±0.1微摩尔/升,BDL组为6.6±0.2微摩尔/升)、肾小球亚硝酸盐生成量(分别为6.4±0.1对9.8±0.1纳摩尔/24小时/7000个肾小球)以及单核淋巴细胞亚硝酸盐生成量(分别为0.3±0.04对0.6±0.12纳摩尔/10⁶个细胞)在BDL组均显著高于SO组。此外,通过蛋白质印迹法检测发现,BDL大鼠的单核淋巴细胞和肾小球中巨噬细胞型iNOS的表达增加。与SO大鼠相比,BDL动物的肾脏还表现出钙非依赖性一氧化氮合酶活性增加。BDL组和SO组大鼠在肾小球中组成型内皮型一氧化氮合酶的表达或全肾中钙依赖性一氧化氮合酶的活性方面未显示出差异。在来自正常大鼠的培养系膜细胞中,添加BDL大鼠的血浆而非SO大鼠的血浆可显著刺激(35%)亚硝酸盐生成并增加巨噬细胞型iNOS的表达。此外,给予优先的iNOS抑制剂氨基胍(AG)后,两组的平均动脉压均剂量依赖性升高,但BDL组(26.5±4.4毫米汞柱)的升高幅度大于SO组(13.6±2.6)。在BDL组中,AG还增加了钠和水的排泄以及肾小球滤过率。相比之下,SO组动物仅有微小的、无统计学意义的变化。因此,这些结果表明,BDL大鼠肾脏、肾小球和单核淋巴细胞中NO的表达、活性及生成均升高,部分原因是一种血浆源性物质刺激了iNOS的形成。氨基胍改善了这些肝硬化动物的动脉低血压及相关排泄水平降低,进一步支持了诱导型一氧化氮合酶同工型参与了BDL动物中观察到的肾脏改变。